These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 1123350)
1. Dihydrotestosterone formation in cultured human fibroblasts. Comparison of cells from normal subjects and patients with familial incomplete male pseudohermaphroditism, Type 2. Wilson JD J Biol Chem; 1975 May; 250(9):3498-504. PubMed ID: 1123350 [TBL] [Abstract][Full Text] [Related]
2. Diminished 5alpha-reductase activity in extracts of fibroblasts cultured from patients with familial incomplete male pseudohermaphroditism, type 2. Moore RJ; Griffin JE; Wilson JD J Biol Chem; 1975 Sep; 250(18):7168-72. PubMed ID: 240819 [TBL] [Abstract][Full Text] [Related]
3. Dihydrotestosterone binding by cultured human fibroblasts. Comparison of cells from control subjects and from patients with hereditary male pseudohermaphroditism due to androgen resistance. Griffin JE; Punyashthiti K; Wilson JD J Clin Invest; 1976 May; 57(5):1342-51. PubMed ID: 177454 [TBL] [Abstract][Full Text] [Related]
4. Aromatization of androstenedione by cultured human fibroblasts. Schweikert HU; Milewich L; Wilson JD J Clin Endocrinol Metab; 1976 Oct; 43(4):785-95. PubMed ID: 977721 [TBL] [Abstract][Full Text] [Related]
5. Intranuclear binding of [3H]dihydrotestosterone by cultured human fibroblasts. Collier ME; Griffin JE; Wilson JD Endocrinology; 1978 Oct; 103(4):1499-505. PubMed ID: 744162 [TBL] [Abstract][Full Text] [Related]
6. Specific 5alpha-dihydrotestosterone binding in labial skin fibroblasts cultured from patients.with male pseudohermaphroditism. Kaufman M; Straisfeld C; Pinsky L Clin Genet; 1976 Jun; 9(6):567-74. PubMed ID: 1277570 [TBL] [Abstract][Full Text] [Related]
7. Human minimal androgen insensitivity with normal dihydrotestosterone-binding capacity in cultured genital skin fibroblasts: evidence for an androgen-selective qualitative abnormality of the receptor. Pinsky L; Kaufman M; Killinger DW; Burko B; Shatz D; Volpé R Am J Hum Genet; 1984 Sep; 36(5):965-78. PubMed ID: 6333813 [TBL] [Abstract][Full Text] [Related]
8. Familial incomplete male pseudohermaphroditism associated with impaired nuclear androgen retention. Studies in cultured skin fibroblasts. Eil C J Clin Invest; 1983 Apr; 71(4):850-8. PubMed ID: 6833492 [TBL] [Abstract][Full Text] [Related]
10. Testosterone 5alpha-reduction in the skin of normal subjects and of patients with abnormal sex development. Kuttenn F; Mauvais-Jarvis P Acta Endocrinol (Copenh); 1975 May; 79(1):164-76. PubMed ID: 1173304 [TBL] [Abstract][Full Text] [Related]
11. Male pseudohermaphroditism presumably due to target organ unresponsiveness to androgens. Deficient 5alpha-dihydrotestosterone binding in cultured skin fibroblasts. Kaufman M; Straisfeld C; Pinsky L J Clin Invest; 1976 Aug; 58(2):345-50. PubMed ID: 182718 [TBL] [Abstract][Full Text] [Related]
12. Hereditary male pseudohermaphroditism associated with an unstable form of 5 alpha-reductase. Leshin M; Griffin JE; Wilson JD J Clin Invest; 1978 Sep; 62(3):685-91. PubMed ID: 29056 [TBL] [Abstract][Full Text] [Related]
13. Abnormality of intracellular 5 alpha-dihydrotestosterone binding in simple hypospadias: studies on equilibrium steroid binding in sonicates of genital skin fibroblasts. Keenan BS; McNeel RL; Gonzales ET Pediatr Res; 1984 Feb; 18(2):216-20. PubMed ID: 6701049 [TBL] [Abstract][Full Text] [Related]
14. High dose androgen therapy in male pseudohermaphroditism due to 5 alpha-reductase deficiency and disorders of the androgen receptor. Price P; Wass JA; Griffin JE; Leshin M; Savage MO; Large DM; Bu'Lock DE; Anderson DC; Wilson JD; Besser GM J Clin Invest; 1984 Oct; 74(4):1496-508. PubMed ID: 6480833 [TBL] [Abstract][Full Text] [Related]
15. Familial incomplete male pseudohermaphroditism, type 2. Decreased dihydrotestosterone formation in pseudovaginal perineoscrotal hypospadias. Walsh PC; Madden JD; Harrod MJ; Goldstein JL; MacDonald PC; Wilson JD N Engl J Med; 1974 Oct; 291(18):944-9. PubMed ID: 4413434 [No Abstract] [Full Text] [Related]
16. A case of male pseudohermaphroditism with normal androgen receptor binding and 47,XYY karyotype. Bosch-Banyeras JM; Audi L; Sarret E; Bau A; Bosch-Marcet J; Bernet M; Iriondo L; Cuatrecasas JM Ann Genet; 1985; 28(2):125-9. PubMed ID: 3876063 [TBL] [Abstract][Full Text] [Related]
17. Male pseudohermaphroditism due to steroid 5-alpha-reductase deficiency. Peterson RE; Imperato-McGinley J; Gautier T; Sturla E Am J Med; 1977 Feb; 62(2):170-91. PubMed ID: 835597 [TBL] [Abstract][Full Text] [Related]
18. Familial male pseudohermaphroditism due to deficiency of 5 alpha-reductase. Savage MO; Preece MA; Jeffcoate SL; Ransley PG; Rumsby G; Mansfield MD; Williams DI Clin Endocrinol (Oxf); 1980 Apr; 12(4):397-406. PubMed ID: 7379320 [TBL] [Abstract][Full Text] [Related]
19. Endocrine and biochemical studies in a 46,XY phenotypically male infant with 17-ketosteroid reductase deficiency. Ulloa-Aguirre A; Bassol S; Poo J; Mendez JP; Mutchinick O; Robles C; Pérez-Palacios G J Clin Endocrinol Metab; 1985 Apr; 60(4):639-43. PubMed ID: 2857728 [TBL] [Abstract][Full Text] [Related]
20. Cultured human skin fibroblasts: a model for the study of androgen action. Brown TR; Migeon CJ Mol Cell Biochem; 1981 Apr; 36(1):3-22. PubMed ID: 7017379 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]